The GISAID sharing mechanism and its data sharing platform are the result of a global collaboration of experts in their respective disciplines working together to facilitate rapid access to data of priority pathogens. The agreement governing the terms of access to and use of the GISAID platform was developed over 18-months (December 2006 through May 2008) in consultation with national public health, animal health and relevant governmental authorities, the influenza research community, and commercial developers of medical interventions. The process of defining the core terms and conditions was led by Peter Bogner (Principle Investigator), with counsel provided by leading experts in their professional fields, in particular with outstanding contributions by:
- Peter Bogner (Broadcasting Executive, Time Warner International, USA)
- Laurie C. Self (Covington & Burling LLP, Washington D.C.)
- Dale D. Berkley (Intellectual Property Counsel at the National Institutes of Health, Bethesda)
- Joseph A. Foster (Office of the General Counsel, US Centers for Disease Control & Prevention, Atlanta)
- Jörg Paura (Hogan Lovells LLP, Hamburg)
- Mark Abdoo (Global Health Affairs at US Department of Health and Human Services)
- Marie Connett (Cambia - Patent Lens, Canberra Australia)
- Pathom Sawanpanyalert (Ministry of Health, Thailand)
- Endang Sedyaningsih (Ministry of Health, Indonesia)
- Lindsey L. Tonsager (Covington & Burling LLP, Washington D.C.)
- Christoph F. Wetzler (Orrick Hölters Elsing, Frankfurt)
- Nancy J. Cox (US Centers for Disease Control & Prevention, Atlanta)
- Rod Daniels (National Institute for Medical Research, London)
- Alan J. Hay (National Institute for Medical Research, London)
- Michael W. Shaw (US Centers for Disease Control & Prevention, Atlanta)
